• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过贝叶斯网络优化药物递送:在尿毒症性贫血促红细胞生成素治疗中的应用

Drug delivery optimization through Bayesian networks: an application to erythropoietin therapy in uremic anemia.

作者信息

Bellazzi R

机构信息

Dipartimento di Informatica e Sistemistica, Universitá di Pavia, Italy.

出版信息

Comput Biomed Res. 1993 Jun;26(3):274-93. doi: 10.1006/cbmr.1993.1019.

DOI:10.1006/cbmr.1993.1019
PMID:8325006
Abstract

This paper describes how Bayesian networks can be used in combination with compartmental models to plan recombinant human erythropoietin delivery in the treatment of anemia of chronic uremic patients. Past measurements of hemoglobin concentration in a patient during the therapy can be exploited to adjust the parameters of a compartmental model of erythropoiesis. This adaptive process provides more accurate patient-specific predictions, and hence a more rational dosage planning. Inferences are performed by using a stochastic simulation algorithm called Gibbs sampling. We describe a drug delivery optimization protocol based on our approach. Some results obtained on real data are presented.

摘要

本文描述了如何将贝叶斯网络与房室模型相结合,以规划重组人促红细胞生成素的给药方案,用于治疗慢性尿毒症患者的贫血。在治疗过程中对患者血红蛋白浓度的既往测量结果可用于调整红细胞生成房室模型的参数。这种自适应过程可提供更准确的患者特异性预测,从而实现更合理的剂量规划。推理是通过使用一种称为吉布斯采样的随机模拟算法进行的。我们基于我们的方法描述了一种药物递送优化方案。展示了在真实数据上获得的一些结果。

相似文献

1
Drug delivery optimization through Bayesian networks: an application to erythropoietin therapy in uremic anemia.通过贝叶斯网络优化药物递送:在尿毒症性贫血促红细胞生成素治疗中的应用
Comput Biomed Res. 1993 Jun;26(3):274-93. doi: 10.1006/cbmr.1993.1019.
2
Drug delivery optimization through Bayesian networks.通过贝叶斯网络优化药物递送
Proc Annu Symp Comput Appl Med Care. 1992:572-8.
3
Simplification of an erythropoiesis model for design of anemia management protocols in end stage renal disease.用于终末期肾病贫血管理方案设计的红细胞生成模型简化
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:83-6. doi: 10.1109/IEMBS.2011.6089902.
4
Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?尿毒症性贫血中促红细胞生成素治疗的数学模型。它能提高成本效益吗?
Haematologica. 1994 Mar-Apr;79(2):154-64.
5
New pharmacoeconomic option in uremic anemia management.
Clin Nephrol. 2007 Mar;67(3):200. doi: 10.5414/cnp67200.
6
Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.在持续非卧床腹膜透析的尿毒症患者中,使用自行每日皮下注射促红细胞生成素纠正贫血。
Int J Artif Organs. 1993 Jul;16(7):510-4.
7
Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin.尿毒症性红细胞生成抑制剂:重组人促红细胞生成素治疗期间的一项研究
Am J Nephrol. 1992;12(1-2):9-13. doi: 10.1159/000168410.
8
[Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].[左旋肉碱与促红细胞生成素联合治疗血液透析慢性肾衰竭患者贫血]
Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):14-9.
9
Darbepoetin alfa therapeutic interchange protocol for anemia in dialysis.用于透析患者贫血的阿法达贝泊汀治疗性互换方案。
Ann Pharmacother. 2005 Nov;39(11):1808-11. doi: 10.1345/aph.1G329. Epub 2005 Sep 27.
10
Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?在临床病房中应用人工神经网络会帮助肾病学家预测促红细胞生成素的反应性吗?
BMC Nephrol. 2006 Sep 18;7:13. doi: 10.1186/1471-2369-7-13.

引用本文的文献

1
Multi-head self-attention mechanism enabled individualized hemoglobin prediction and treatment recommendation systems in anemia management for hemodialysis patients.多头自注意力机制助力于为血液透析患者的贫血管理建立个性化血红蛋白预测及治疗推荐系统。
Heliyon. 2023 Feb 1;9(2):e12613. doi: 10.1016/j.heliyon.2022.e12613. eCollection 2023 Feb.
2
The Role of Feedback Control Design in Developing Anemia Management Protocols.反馈控制设计在开发贫血管理方案中的作用。
Ann Biomed Eng. 2021 Jan;49(1):171-179. doi: 10.1007/s10439-020-02520-1. Epub 2020 May 7.
3
Individualized drug dosing using RBF-Galerkin method: Case of anemia management in chronic kidney disease.
使用径向基函数伽辽金方法的个体化给药:慢性肾脏病贫血管理案例
Comput Methods Programs Biomed. 2017 Sep;148:45-53. doi: 10.1016/j.cmpb.2017.06.008. Epub 2017 Jun 23.
4
Predictive modeling for improved anemia management in dialysis patients.预测模型可改善透析患者的贫血管理。
Curr Opin Nephrol Hypertens. 2011 Nov;20(6):573-6. doi: 10.1097/MNH.0b013e32834bba4e.
5
Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?在临床病房中应用人工神经网络会帮助肾病学家预测促红细胞生成素的反应性吗?
BMC Nephrol. 2006 Sep 18;7:13. doi: 10.1186/1471-2369-7-13.
6
Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.
Clin Pharmacokinet. 2004;43(1):57-70. doi: 10.2165/00003088-200443010-00004.
7
Timing is everything. Time-oriented clinical information systems.时机就是一切。面向时间的临床信息系统。
West J Med. 1998 Feb;168(2):105-13.